The inaugural Palm Conversations International India conference, hosted by the Malaysian Palm Oil Council, brought together experts to discuss emerging scientific evidence on palm oil, dietary habits, and health outcomes. Discussions focused on moving beyond fat content to evaluate overall dietary intake, molecular structure, and ongoing research into palm-derived bioactives.

The inaugural Palm Conversations International India 2026 (PCI) conference was held under the theme ‘Bioactive power from the palm: Reimagining health for a world facing non-communicable diseases (NCDs)’. Hosted by the Malaysian Palm Oil Council (MPOC), the event brought together researchers, healthcare professionals, nutrition experts, policymakers, and industry stakeholders to examine emerging evidence on Malaysian palm oil and its naturally occurring bioactive compounds.

The conference served as a platform for MPOC to continue building scientific and trade ties with India, which remains one of Malaysia’s largest palm oil export markets. Belvinder Sron, Chief Executive Officer of MPOC, stated that the event provides a platform for open, evidence-based scientific dialogue to explore how science and nutrition can contribute to healthier lives, while deepening collaboration between Malaysia and India in science, nutrition, healthcare, and innovation.

Scientific presentations at the conference called for a broader understanding of palm oil that goes beyond its fat content. Experts emphasized taking into account overall dietary intake, molecular structure, cooking behaviour, and health outcomes. Vishal Malhotra, Senior Consultant – Healthcare at Makreo Research and Consulting, India, noted that India’s annual per-capita edible oil consumption is approximately 23.5 kg, compared to the Indian Council of Medical Research (ICMR) recommended level of around 12 kg, highlighting the importance of balanced diets.

A review of cardiovascular evidence presented at the conference screened 4,515 citations and found no consistent association between palm oil consumption and heart disease, stroke, or cardiovascular mortality, while acknowledging limitations in the available evidence. Presentations also highlighted that palm oil’s naturally semi-solid structure allows it to provide functionality without partial hydrogenation, distinguishing it from industrial trans fats. Its thermal and oxidative stability was also discussed as a relevant consideration in cooking practices.

The conference also examined the emerging science of palm-derived bioactives, specifically tocotrienols and palm phenolics, and their potential relevance to NCDs. Roger Clemens, Adjunct Professor at the University of Southern California, USA, discussed early research exploring their potential role in areas including cardiovascular health and inflammation. Experts stressed that this remains an evolving area of research, with further studies needed to establish safety, dosage, bioavailability, and clinical significance.

Furthermore, experts emphasized that palm-derived bioactives are an emerging area of study and are not substitutes for established NCD prevention or treatment. The discussions called for moving beyond perceptions and labels to evaluate balanced diets, cooking practices, and clinical evidence. The event received support from the Indian Medical Association, the International Association of Dietitians for Metabolic Health and Nutrition, and the Oil Technologists’ Association of India.

"Industry dialogues that bring together scientific research, trade bodies, and policymakers are crucial for transparency and evidence-based decision-making. As consumer markets like India navigate complex patterns in food consumption and health, stakeholder engagements focusing on clinical data, dietary balance, and practical industry applications help ground commercial practices in verified science rather than general perceptions." — Dr. Shishir Gupta, Founder & CEO, StartupLanes

Recent StartupLanes Articles

Browse through our 30 latest publications on venture capital, startups, and angel investing.

Kalpataru Projects International Secures New Orders Worth ₹2,349 Crore Oct 22, 2026
MCX Copper Futures Decline From Recent Highs as Market Approaches Key Support Levels Oct 22, 2026
OpenAI Acquires Orchestra Bio to Expand Life Sciences and Drug Development Capabilities Oct 22, 2026
Dr. Reddy’s Laboratories Receives DCGI Approval for Toripalimab in India Oct 22, 2026
Anthropic's Confidential IPO Filing Reveals $80.7 Billion H1 Loss and Heavy Computing Costs Oct 22, 2026
Jio Platforms Launches ₹30,213 Crore IPO: Key Details, Valuations, and Brokerage Views Oct 22, 2026
State Bank of India Reports Suspected Customer Data Exposure on Dark Web Oct 22, 2026
US Secretary of State Marco Rubio Terms Envoy Meeting with Ukrainian President Positive Oct 22, 2026
Rupee Strengthens 29 Paise Against US Dollar in Early Trade, Supported by RBI and Jio IPO Inflows Oct 22, 2026
Brent Crude Stays Above $110 Amid West Asia Supply Concerns and Inventory Data Oct 22, 2026
Indian Market Updates: Corporate Earnings, Strategic Agreements, and Expansion Plans Across Sectors Oct 22, 2026
Corporate Updates: Infosys Expands Truist Collaboration, Cemindia Raises ₹1,400 Crore via QIP, and Multiple Firms Report Contracts and Acquisitions Oct 22, 2026
Centre to Review National Mineral Policy 2019 to Focus on Critical Minerals and Deep-Sea Resources Oct 22, 2026
Qualcomm Announces Global Job Cuts Following Annual Performance Reviews Oct 22, 2026
AstraZeneca Pharma Relocates Registered Office from Karnataka to Maharashtra Oct 22, 2026